Opko Health (OPK) Change in Receivables (2010 - 2026)
Opko Health's (OPK) quarterly Change in Receivables came in at $2.4 million in Q2 2026, down 37.4% YoY from $3.8 million in Q2 2025, and up 125.07% on a QoQ basis from -$9.5 million in Q1 2026.
Opko Health (OPK) Change in Receivables (2010 - 2026) Analysis & Trends
Opko Health (OPK) has 17 years of Change in Receivables data on file, last reported at $2.4 million in Q2 2026.
- Quarterly Change in Receivables fell 37.4% year-over-year to $2.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$18.2 million (up 63.64% YoY) and the FY2025 annual result came in at -$30.2 million, down 13833.18% from the prior year.
- Change in Receivables advanced to $2.4 million in Q2 2026, from -$9.5 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $89.2 million in Q2 2023 to a low of -$90.6 million in Q3 2023.
- A 5-year average of -$12.3 million and a median of -$9.5 million in 2024 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables tumbled 350.91% — and 2023, when it soared 273.37%.
- Tracing OPK's Change in Receivables over 5 years: stood at $1.4 million in 2022, then jumped by 267.59% to $5.3 million in 2023, then slumped by 394.18% to -$15.7 million in 2024, then surged by 57.21% to -$6.7 million in 2025, then jumped by 135.59% to $2.4 million in 2026.
- The last three Change in Receivables figures came in at $2.4 million (Q2 2026), -$9.5 million (Q1 2026), and -$6.7 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -71.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 26.04 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -12.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 121.07 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 26.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 25.09 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 79.00 Mn |
| 10 | Opko Health | 1.02 Bn | 718.85 Mn | 80.02 Mn | 2.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.39 Mn |
| Jun 30, 2026 | 2.39 Mn |
| Mar 31, 2026 | -9.53 Mn |
| Mar 31, 2026 | -9.53 Mn |
| Dec 31, 2025 | -6.71 Mn |
| Dec 31, 2025 | -6.71 Mn |
| Sep 30, 2025 | -4.39 Mn |
| Sep 30, 2025 | -4.39 Mn |
| Jun 30, 2025 | 3.82 Mn |
| Jun 30, 2025 | 3.82 Mn |
| Mar 31, 2025 | -22.93 Mn |
| Mar 31, 2025 | -22.93 Mn |
| Sep 30, 2024 | -15.68 Mn |
| Sep 30, 2024 | -15.68 Mn |
| Jun 30, 2024 | -15.35 Mn |
| Jun 30, 2024 | -15.35 Mn |
| Mar 31, 2024 | -9.52 Mn |
| Mar 31, 2024 | -9.52 Mn |
| Dec 31, 2023 | 5.33 Mn |
| Dec 31, 2023 | 5.33 Mn |